ABCs of Asthma

Clinical Cornerstone

Volumn 8, Issue 4, 2008, Pages 9-25

  Bernstein, David I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYTOKINE; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; NEDOCROMIL; NITRIC OXIDE; OMALIZUMAB; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN D2; THEOPHYLLINE; THROMBOCYTE ACTIVATING FACTOR; TOBACCO SMOKE; TUMOR NECROSIS FACTOR ALPHA; ZILEUTON;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CELL ACTIVATION; CHEST TIGHTNESS; CLINICAL EXAMINATION; COCKROACH; CYTOKINE RELEASE; DANDER; DERMATOPHAGOIDES; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; DRUG UTILIZATION; DYSPNEA; EARLY INTERVENTION; ENVIRONMENTAL FACTOR; EOSINOPHILIA; EPITHELIUM CELL; EXERCISE TEST; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; HYPOTHESIS; LEUKOCYTE ACTIVATION; LOW DRUG DOSE; LUNG FUNCTION TEST; MACROPHAGE ACTIVATION; MAST CELL; MEDICAL ASSESSMENT; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; MOULD; OSCILLOMETRY; OUTPATIENT CARE; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PEAK EXPIRATORY FLOW; POLLEN; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; SELF CARE; SENSITIZATION; SEVERE PERSISTENT ASTHMA; SPIROMETRY; SPUTUM ANALYSIS; SYMPTOM; T LYMPHOCYTE ACTIVATION; WHEEZING;

ANTI-ASTHMATIC AGENTS; ASTHMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; RISK FACTORS;

EID: 49349110693     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(08)80010-5     Document Type: Article

References (36)

1. American Lung Association. Trends in asthma morbidity and mortality. American Lung Association Epidemiology & Statistics Unit Research and Program Services, July 2006.
2. (February 21, 2008). http://www.lungusa.org Accessed
3. Holgate S.T., and Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet. 368 (2006) 780-793
4. Betancourt J.R., and Maina A.W. The Institute of Medicine report "Unequal Treatment": Implications for academic health centers. Mt Sinai J Med. 71 (2004) 314-321
5. Center for Disease Control. CDC National Center for Health Statistics. National Asthma Control Program: Improving Quality of Life and Reducing Costs 2005. At a Glance.
6. (February 21, 2008). http://www.cdc.gov/asthma/pdfs/aag05.pdf Accessed
7. Reed C.E. The natural history of asthma. J Allergy Clin Immunol. 118 (2006) 543-548
8. National Asthma Education and Prevention Program (NAEPP). Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, Full Report 2007. Bethesda, Md: National Heart, Lung, and Blood Institute; August 2007. NIH Publication No. 07-4051.
9. (March 5, 2008). http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm Accessed
10. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA). National Institutes of Health. NIH Publication No. 02-3659. National Heart, Lung, and Blood Institute (NHLBI) 2006.
11. (March 5, 2008). http://www.ginasthma.com Accessed
12. National Asthma Education and Prevention Program (NAEPP). Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health (NIH) Publication No. 97-4051. Washington, DC; National Heart, Lung, and Blood Institute (NHLBI) 1997.
13. (March 5, 2008). http://www.nhlbi.nih.gov/guidelines/archives/epr-2/ Accessed
14. Meltzer E.O. The relationships of rhinitis and asthma. Allergy Asthma Proc. 26 (2005) 336-340
15. Canonica G.W. Treating asthma as an inflammatory disease. Chest 130 (2006) 21S-28S
16. Busse W.W., and Lemanske R.F. Asthma. New Engl J Med. 344 (2001) 350-362
17. Bradding P., Walls A.F., and Holgate S.T. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol. 117 (2006) 1277-1284
18. National Asthma Education and Prevention Program (NAEPP). Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Update on Selected Topics 2002. National Institutes of Health (NIH) Publication No. 02-5074. Washington, DC; National Heart, Lung, and Blood Institute (NHLBI) 2003.
19. (March 11, 2008). http://www.nhlbi.nih.gov/guidelines/archives/epr-2_upd/index.htm Accessed
20. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA). National Institutes of Health. NIH Publication No. 02-3659. National Heart, Lung, and Blood Institute (NHLBI) 2005.
21. (March 14, 2008). http://www.ginasthma.com Accessed
22. Hauber H.P., Gotfried M., Newman K., et al. Effect of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol. 112 (2003) 58-63
23. Barnes P.J. New directions in allergic diseases: Mechanism-based anti-inflammatory therapies. J Allergy Clin Immunol. 106 (2000) 5-16
24. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program (CAMP) Research Group. N Engl J Med. 343 (2000) 1054-1063
25. Suissa S., Ernst P., Benayoun S., et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 343 (2000) 332-336
26. Boehmer A.L., and Merkus P.J. Asthma therapy for children under 5 years of age. Curr Opin Pulm Med. 12 (2006) 34-41
27. Wenzel S.E. Asthma: Defining of the persistent adult phenotypes. Lancet. 368 (2006) 804-813
28. Strek M.E. Difficult asthma. Proc Am Thorac Soc. 3 (2006) 116-123
29. Cookson W., and Moffatt M. Making sense of asthma genes. N Engl J Med. 351 (2004) 1794-1796
30. Fireman P. Understanding asthma pathophysiology. Allergy Asthma Proc. 24 (2003) 79-83
31. Johnston N.W., and Sears M.R. Asthma exacerbations. 1: Epidemiology. Thorax 61 (2006) 722-728
32. Tovar J.M., and Gums J.G. Monitoring pulmonary function in asthma and COPD: Point-of-care testing. Ann Pharmacother. 38 (2004) 126-133
33. Nieto A., Pamies R., Oliver F., et al. Montelukast improves pulmonary function measured by impulse oscillometry in children with asthma (Mio study). Respir Med. 100 (2006) 1180-1185
34. Marotta A., Klinnert M.D., Price M.R., et al. Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma. J Allergy Clin Immunol. 112 (2003) 317-322
35. Moore W.C., and Peters S.P. Severe asthma: An overview. J Allergy Clin Immunol. 117 (2006) 487-494
36. Smith A.D., Cowan J.O., Brassett K.P., et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 352 (2005) 2163-2173